Teams at Kernal Biologics, Inc.

Lead preclinical immunology for mRNA therapeutics: design, execute and analyze pharmacology, toxicology and DMPK studies for in vivo CAR-T programs; manage CROs and cross-functional partners; prepare regulatory filings (IND/HREC) and program updates; oversee timelines, budgets, risk mitigation, and TPPs.

Lead analytical method development and execution for mRNA and targeted LNP programs, focusing on biophysical and biochemical characterization, antibody-lipid conjugate analytics, CRO oversight, regulatory-compliant method qualification, and authoring analytical sections for INDs and other submissions.